Queen Mary University of London-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Queen Mary University of London - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013356
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Queen Mary University of London (Queen Mary), formerly Queen Mary and Westfield College, a subsidiary of University of London, is a research university that offers undergraduate and postgraduate education; and research programs. The university provides graduation and education services in areas of astrophysics, biological and chemical sciences, business and management, comparative literature, computer science, drama, economics and finance; electronic engineering, english, film studies, law, linguistics, materials, mathematical sciences and others. It also provides national research assessments and research funding programs. The university provides education services to students in the UK and abroad. Queen Mary is headquartered in London, the UK.

Queen Mary University of London – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Queen Mary University of London, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Queen Mary University of London, Medical Devices Deals, 2011 to YTD 2017 9
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Queen Mary University of London, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Queen Mary University of London Enters into Research Agreement with Takeda Pharma 11
Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 12
BioInvent And Cancer Research Technology Enter Into Co-Development Agreement With Queen Mary, University of London 14
MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 15
Licensing Agreements 16
BioMoti Enters into Licensing Agreement with Queen Mary University of London 16
MultiVir Enters into Licensing Agreement with Queen Mary University of London 17
Acquisition 18
Retroscreen Virology Acquires Activiomics for USD6.7 Million 18
Queen Mary University of London – Key Competitors 20
Queen Mary University of London – Key Employees 21
Queen Mary University of London – Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Government and Public Interest 23
Jul 14, 2017: Queen Mary University of London: Awarded £8.6m for global health research 23
Feb 07, 2017: NattoPharma Named Partner For Horizon 2020 EU Research Grant 24
Dec 12, 2016: White blood cell treatment could prevent leading cause of fetal death 25
Sep 14, 2016: Barts Health NHS Trust: £6.5m grant to launch new heart disease Biomedical Research Centre 26
May 24, 2016: Vitamin A may help improve pancreatic cancer chemotherapy 28
Mar 28, 2016: Structure of Parkinson’s protein could lead to new diagnostic and treatment options 29
Feb 11, 2016: Common antimalarial drug could be used to treat major injury 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Queen Mary University of London, Pharmaceuticals & Healthcare, Key Facts 2
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Queen Mary University of London, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Queen Mary University of London, Deals By Therapy Area, 2011 to YTD 2017 8
Queen Mary University of London, Medical Devices Deals, 2011 to YTD 2017 9
Queen Mary University of London, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Queen Mary University of London Enters into Research Agreement with Takeda Pharma 11
Cancer Research Technology Enters Into Co-Development Agreement With ADC Therapeutics For Antibody Drug Conjugates 12
BioInvent And Cancer Research Technology Enter Into Co-Development Agreement With Queen Mary, University of London 14
MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 15
BioMoti Enters into Licensing Agreement with Queen Mary University of London 16
MultiVir Enters into Licensing Agreement with Queen Mary University of London 17
Retroscreen Virology Acquires Activiomics for USD6.7 Million 18
Queen Mary University of London, Key Competitors 20
Queen Mary University of London, Key Employees 21
Queen Mary University of London, Subsidiaries 22

★海外企業調査レポート[Queen Mary University of London-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Camden Property Trust:企業の戦略・SWOT・財務情報
    Camden Property Trust - Strategy, SWOT and Corporate Finance Report Summary Camden Property Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Intersurgical Ltd.:企業の戦略的SWOT分析
    Intersurgical Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Knott’s Berry Farm:企業の戦略的SWOT分析
    Knott's Berry Farm - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Discount Tire Co.:企業の戦略・SWOT・財務情報
    Discount Tire Co. - Strategy, SWOT and Corporate Finance Report Summary Discount Tire Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Chang Hwa Commercial Bank, Ltd.:企業の戦略・SWOT・財務情報
    Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Chang Hwa Commercial Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Bank of Chongqing Co Ltd:企業の戦略・SWOT・財務分析
    Bank of Chongqing Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of Chongqing Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Dynasil Corporation of America (DYSL)-医療機器分野:企業M&A・提携分析
    Summary Dynasil Corporation of America (Dynasil) is an electronic equipment company that develops and manufactures optics and photonics products. The company also offers optical detection and analysis technology and components. It provides products such as beamsplitters, diffraction gratings, infrar …
  • Banco Bilbao Vizcaya Argentaria Colombia SA:企業の戦略・SWOT・財務分析
    Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bilbao Vizcaya Argentaria Colombia SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Aurora Energy Pty Ltd:企業の戦略・SWOT・財務分析
    Aurora Energy Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Aurora Energy Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Abeona Therapeutics Inc (ABEO)-医療機器分野:企業M&A・提携分析
    Summary Abeona Therapeutics Inc (Abeona), formerly PlasmaTech Biopharmaceuticals, Inc., is a biopharmaceutical company focusing on the development and delivery of gene therapy and plasma-based products for severe and life-threatening rare diseases. The company’s lead programs include ABO-101 and ABO …
  • United Breweries Limited:企業の戦略・SWOT・財務情報
    United Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary United Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Swiss Life Holding Ltd:企業のM&A・事業提携・投資動向
    Swiss Life Holding Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Life Holding Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Pfizer Inc (PFE):企業の財務・戦略的SWOT分析
    Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Challenger Ltd.:企業の戦略・SWOT・財務情報
    Challenger Ltd. - Strategy, SWOT and Corporate Finance Report Summary Challenger Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Newpark Resources Inc (NR):企業の財務・戦略的SWOT分析
    Newpark Resources Inc (NR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • DigitalGlobe Inc:企業の戦略的SWOT分析
    DigitalGlobe Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Emco Ltd (EMCO):電力:M&Aディール及び事業提携情報
    Summary Emco Ltd (Emco) is a power company that manufactures and markets electrical products and solutions. The company's products include transformers, substations, energy metering systems, and transmission towers and lines. Its transformers comprise furnace transformers, distribution transformers, …
  • Hansen Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hansen Medical Inc (Hansen Medical), formerly Autocath Inc, a subsidiary of Auris Health Inc, is a medical device company that develops, manufactures and markets magellan robotic system for peripheral vascular intervention. The company’s products comprise robotic system, robotic catheters, s …
  • Power Machines-エネルギー分野:企業M&A・提携分析
    Summary Power Machines is a power engineering company that designs, manufactures and delivers equipment for thermal, nuclear, hydraulic and gas turbine power plants. The company offers steam, gas and hydraulic turbines, turbo-generators, hydraulic generators, blades for steam and gas turbines and ex …
  • Alliance Data Systems Corp (ADS):企業の財務・戦略的SWOT分析
    Alliance Data Systems Corp (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆